Record number:
926
Adverse Occurrence type:
MPHO Type:
Estimated frequency:
Most recent risk assessment for leukemia, lymphoma and plasmacytoma (Council of Europe, 2022):
Leukaemia, lymphoma and plasmacytoma diagnosed during donor procurement: These cancers are classified as an unacceptable risk for organ donation. Leukaemia, lymphoma and plasmacytoma in the donor history: Active (acute or chronic) leukaemia, lymphoma and plasmacytoma are an unacceptable risk for organ donation. Treated acute leukaemia and lymphoma after a definite disease-free interval of 10 years may be considered for organ donation with an assumed high risk for transmission.
Time to detection:
1.5 months
Alerting signals, symptoms, evidence of occurrence:
Reported to DTAC 1.5 months posttransplant (not reported which recipient was the first) - no alerting signals published
Demonstration of imputability or root cause:
DTAC (Disease Transmission Advisory Committee) classifies transmission as "proven" (laboratory evidence of same maligancy in different recipients of same donor)
Suggest references:
aaa